Nasal Decolonisation / Recurrent Epistaxis
Pregnancy: Topical use considered acceptable — minimal systemic absorption; used in pregnancy for epistaxis prevention
Naseptin Nasal Cream
Brand names: Naseptin
Adult dose
Dose: Small amount applied inside each nostril
Route: Intranasal (topical)
Frequency: Four times daily for 10 days (decolonisation); twice daily (long-term — recurrent epistaxis prevention)
Max: Four times daily application
Contains chlorhexidine 0.1% + neomycin 0.5%. Used for: (1) MRSA/Staphylococcus aureus nasal decolonisation pre-operatively; (2) prevention of recurrent anterior epistaxis (moisturises Little's area and provides antibacterial effect to reduce nasal crusting and picking). Also used post-nasal surgery.
Paediatric dose
Dose: Small amount per nostril application/kg
Route: Intranasal
Frequency: Four times daily for 10 days
Max: Same as adults
BNFc: licensed in children. Apply with cotton bud or fingertip inside nares. Avoid in neonates — chlorhexidine absorption risk.
Dose adjustments
Renal
No dose adjustment required (topical)
Hepatic
No dose adjustment required
Paediatric weight-based calculator
BNFc: licensed in children. Apply with cotton bud or fingertip inside nares. Avoid in neonates — chlorhexidine absorption risk.
Clinical pearls
- Pre-surgical MRSA decolonisation: standard 5-day protocol — Naseptin QDS (nose) + chlorhexidine body wash; reduces surgical site infection rate
- Recurrent epistaxis prevention: antiseptic/moisturising nasal cream applied twice daily reduces crusting and the urge to pick — targets the cycle of Kiesselbach's plexus trauma
- Neomycin component: aminoglycoside; sensitisation occurs with repeated long-term use — consider alternatives if contact dermatitis develops
- Contains arachis (peanut) oil in the original formulation — check for peanut/soya allergy before prescribing; alternatives without arachis oil are available
- Not effective for MRSA decolonisation alone — mupirocin nasal ointment (Bactroban) is superior for MRSA decolonisation (targets MRSA specifically); Naseptin used for general Staph aureus decolonisation
Contraindications
- Neomycin hypersensitivity or allergy to aminoglycosides
- Peanut/soya allergy (contains arachis oil — check formulation)
- Perforated tympanic membrane (if used near ear)
Side effects
- Local irritation
- Contact sensitisation to neomycin (with prolonged use)
- Skin dryness
Interactions
- Negligible at topical doses
Monitoring
- Decolonisation swab (post-treatment)
- Skin sensitisation (prolonged use)
Reference: BNFc; BNF 90; BNFc; NICE Surgical Site Infection (SSI) Prevention Guidance; PHE MRSA Decolonisation Protocol. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- DASH Prediction Score for Recurrent VTE · VTE Risk
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- Lund-Mackay CT Score for Chronic Rhinosinusitis · Sinonasal
- EpiScore for Epistaxis Severity · Epistaxis
- SNOT-22 (Sinonasal Outcome Test) · Chronic Rhinosinusitis
- Epistaxis Severity Score (ESS) · Epistaxis